• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Alcon Inc.

    5/28/25 11:32:20 AM ET
    $ALC
    Ophthalmic Goods
    Health Care
    Get the next $ALC alert in real time by email
    SD 1 alconformsd31dec2024.htm SD Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    FORM SD
    SPECIALIZED DISCLOSURE REPORT



    Alcon Inc.
    (Exact name of the registrant as specified in its charter)

    Switzerland001-31269
    (State or other jurisdiction of
    incorporation or organization)
    (Commission File Number)


    Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland
    (Address of principal executive offices)



    Royce Bedward
    Senior Vice President, General Counsel & Corporate Secretary
    Chemin de Blandonnet 8, 1214 Vernier, Geneva, Switzerland
    Tel: +41 58 911 20 00
    (Name and telephone number, including area code, of the
    person to contact in connection with this report.)




    Check the appropriate box to indicate the rule pursuant to which this form is being filed:

    _X_ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.
    ___ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended ______.





    Section 1. Conflict Minerals Disclosure
    Item 1.01 Conflict Minerals Disclosure and Report
    In accordance with Rule 13p-1 under the Securities Exchange Act of 1934, Alcon Inc. has filed this Specialized Disclosure Form (Form SD) and the associated Conflict Minerals Report. Both reports are posted and publicly available at the Alcon corporate website: https://www.alcon.com/about-us/commitment-integrity-and-compliance/

    Item 1.02 Exhibit
    The Conflict Minerals Report is attached as Exhibit 1.01.

    Section 2. Resource Extraction Issuer Disclosure
    Item 2.01 Resource Extraction Issuer Disclosure and Report
    Not applicable.

    Section 3. Exhibits
    Item 3.01 Exhibits
    Exhibit No.     Description
    1.01Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form






    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
    ALCON INC.
    Date:May 28, 2025By:/s/ Royce Bedward
    Name: Royce Bedward
    Title: Authorized Representative
    Date:May 28, 2025By:/s/ Tom Hudnall
    Name: Tom Hudnall
    Title: Authorized Representative

    Get the next $ALC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALC

    DatePrice TargetRatingAnalyst
    5/20/2025Buy → Hold
    Deutsche Bank
    5/14/2025$102.00 → $99.00Buy
    BTIG Research
    3/28/2025$107.00 → $110.00Buy
    Needham
    3/25/2025Neutral → Buy
    BofA Securities
    1/24/2025$108.00 → $106.00Buy
    Needham
    1/10/2025Neutral → Buy
    Redburn Atlantic
    12/17/2024$103.00 → $108.00Buy
    Needham
    11/12/2024Buy
    Needham
    More analyst ratings